Biocept Inc. Cash Flow-to-Debt Ratio
Biocept Inc. cash flow-to-debt ratio. Biocept Inc. (BIOCQ) has a Cash Flow-to-Debt Ratio of -0.14x as of June 2023, meaning its operating cash flow of $-3.09 Million could theoretically repay 0% of its total liabilities ($21.81 Million) in one year. See how financially flexible is Biocept Inc. to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Biocept Inc. (2019–2022)
Cash flow-to-debt ratio of Biocept Inc. from 2019 to 2022. Historical debt coverage capacity for Biocept Inc. across 4 annual periods. Check Biocept Inc. (BIOCQ) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Biocept Inc. Cash Flow-to-Debt Ratio by Year (2019–2022)
Biocept Inc. cash flow-to-debt ratio by year from 2019 to 2022. Year-by-year debt coverage analysis for Biocept Inc.. For the full cash flow conversion analysis, see cash efficiency ratio of Biocept Inc..
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2022 | -0.60x | $-13.29 Million | $22.01 Million | ▼ -475.3% |
| 2021 | 0.16x | $3.69 Million | $22.94 Million | ▲ +119.3% |
| 2020 | -0.83x | $-19.79 Million | $23.76 Million | ▲ +76.4% |
| 2019 | -3.53x | $-23.05 Million | $6.53 Million | — |